Medicines Shortages

Introduction

A Guide to Managing Medicines Supply and Shortages outlines the national, regional, and local management and communication routes for medicines supply issues to ensure continuity of supply and ensure that patients receive the treatment and medication required.

NHS Business Services Authority (NHSBSA) regularly updates its Serious Shortage Protocols (SSP) page.

Specialist Pharmacy Service (SPS) have created the Medicines Supply Tool, which contains the latest information on supply issues and further guidance. A username and password is required.

For further details to support health professionals and clinical teams in North West London, local prescribing guidance has been developed in partnership with our clinical experts.

Guidance

What good looks like: Guiding principles to support NW London Community Pharmacies and Primary Care Networks (& GP Practices) in managing medicines supply shortages

This guidance supports primary care clinicians in managing medicine supply shortages, focusing on community pharmacies and GP practices.

Summary of guiding principles to support NW London Community Pharmacies and Primary Care Networks (& GP Practices) in managing medicines supply shortages.

This guidance supports primary care clinicians in managing medicine supply shortages, focusing on community pharmacies and GP practices.

Medicines Shortage Notifications

Medicines Shortage Notification Supply problems with Medicines for ADHD

This document provides guidance on managing supply disruptions of methylphenidate MR tablets and switching between preparations. It supports the healthcare system in handling ADHD medication shortages.
Revised: February 2025

North West London Briefing document: Pancreatic Enzyme Replacement Therapy (PERT) shortages

This document provides a summary of key recommendations for managing Pancreatic Enzyme Replacement Therapy (PERT) supply disruption.
Revised: February 2025

Update March 2024: Glucagon-Like-Peptide 1 Receptor Agonist (GLP-1 RA) National Shortage

This updated guidance from the Primary Care Diabetes Society and the Association of British Clinical Diabetologists provides advice on selecting alternative glucose-lowering therapies when GLP-1 RAs used in the management of type 2 diabetes in adults are unavailable.

 

Accessibility tools

Return to header